摘要:
Objective To explore the clinical effect of Wuzhi capsules on drug-induced liver injury in patients undergoing chemotherapy. Methods Totally 74 patients with drug-induced liver injury after chemotherapy in our hospital were randomly divided into observation group and control group. Patients in observation group (n = 36) were treated with Wuzhi capsules combined with reduced glutathione, while patients in control group (n = 36) were only given reduced glutathione. Changes in blood ALT and AST levels were observed after 1 week of treatment, and qualification rate of liver function was followed up before chemotherapy of next cycle. Results At the end of 1 week of treatment, the serum ALT in observation group and control group were both decreased significantly [ (48. 86 ± 18. 20) U/L vs. (122. 92 ± 28. 02) U/L, (57. 76 ± 17. 92) U/L vs. (121. 37 ± 22. 89) U/L, P < 0. 01], and there were significant differences between the two groups (P < 0. 05) ; the serum AST in observation group and control group were both decreased significantly [ (57. 31 ± 21. 07) U/L vs. (135. 06 ± 25. 21) U/L, (68. 05 ± 20. 28) U/L vs. (135. 26 ± 21. 22) U/L, P < 0. 01], and there were significant differences between the two groups (P < 0. 05) . The qualification rate of liver function before chemotherapy of next cycle in observation group was higher than that in control group (97. 22%vs. 76. 32%, P < 0. 01) . Conclusion Wuzhi capsules combined with reduced glutathione can significantly decrease the serum ALT and AST levels in patients with drug-induced liver injury during chemotherapy with good efficacy.%目的 探讨五酯胶囊对化疗所致药物性肝损伤的临床疗效.方法 选择我院收治的74例符合化疗后药物性肝损伤诊断标准的患者, 随机分为2组.观察组36例, 给予五酯胶囊联合还原型谷胱甘肽治疗;对照组38例, 给予还原型谷胱甘肽治疗.观察两组患者血ALT、AST水平变化, 并随访下一周期化疗前肝功能合格率.结果 治疗1周后, 观察组、对照组患者的血ALT均降低[ (48. 86±18. 20) U/L vs. (122. 92±28. 02) U/L, (57. 76±17. 92) U/L vs. (121. 37±22. 89) U/L, P <0. 01], 且两组比较差异有统计学意义 (P <0. 05) ;观察组、对照组患者血AST均降低[ (57. 31±21. 07) U/L vs. (135. 06±25. 21) U/L, (68. 05±20. 28) U/L vs. (135.26±21. 22) U/L, P <0. 01], 且两组比较差异有统计学意义 (P <0. 05) .观察组下一周期化疗前肝功能合格率高于对照组 (97. 22%vs. 76. 32%, P <0. 01) .结论 五酯胶囊联合还原型谷胱甘肽可显著降低化疗药物性肝损害患者血ALT、AST水平, 疗效良好.